Meridian Bioscience Inc (NASDAQ:VIVO)
| 20.47 Delayed Data As of May 07 |  +1.30 / +6.78%Today’s Change | 12.98 Today|||52-Week Range 30.65 | +9.52% Year-to-Date |
Latest VIVO News | Press Releases
| Meridian Bioscience Stock Is Estimated To Be Fairly Valued 1:12am / GuruFocus News - Paid Partner Content | Meridian Bioscience (VIVO) Beats Q2 Earnings Estimates May 07 / Zacks.com - Paid Partner Content |
| Meridian Bioscience (VIVO) Outpaces Stock Market Gains: What You Should Know May 07 / Zacks.com - Paid Partner Content | Meridian Bioscience (VIVO) Reports Next Week: Wall Street Expects Earnings Growth Apr 30 / Zacks.com - Paid Partner Content |
| Meridian Bioscience Inc (VIVO) Q2 2021 Earnings Call Transcript May 07 / MotleyFool.com - Paid Partner Content | Meridian Bioscience (VIVO) Dips More Than Broader Markets: What You Should Know Apr 28 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 19.17 |
| Today’s open | 19.06 |
| Day’s range | 18.89 - 20.74 |
| Volume | 27,943 |
| Average volume (3 months) | 737,551 |
| Market cap | $881.0M |
Data as of 3:59pm ET, 05/07/2021
Growth & Valuation
| Earnings growth (last year) | +88.18% |
| Earnings growth (this year) | +60.05% |
| Earnings growth (next 5 years) | +17.00% |
| Revenue growth (last year) | +26.19% |
| P/E ratio | 12.7 |
| Price/Sales | 2.89 |
| Price/Book | 3.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TRILTrillium Therapeutic... | +0.31 | +3.34% |
| CLDXCelldex Therapeutics... | +0.69 | +2.60% |
| AWHAspira Women's Healt... | +0.27 | +5.49% |
| ---- |
Data as of 4:00pm ET, 05/07/2021
Financials
| Next reporting date | July 29, 2021 |
| EPS forecast (this quarter) | $0.35 |
| Annual revenue (last year) | $253.7M |
| Annual profit (last year) | $46.2M |
| Net profit margin | 18.21% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cincinnati, Ohio |
Forecasts
